Operating Income (Loss) in USD of Anixa Biosciences Inc from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Anixa Biosciences Inc quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q2 2025.
  • Anixa Biosciences Inc Operating Income (Loss) for the quarter ending 31 Jul 2025 was -$2.44M, a 32.2% increase year-over-year.
  • Anixa Biosciences Inc Operating Income (Loss) for the twelve months ending 31 Jul 2025 was -$12M, a 12.6% increase year-over-year.
  • Anixa Biosciences Inc annual Operating Income (Loss) for 2024 was -$13.8M, a 25.6% decline from 2023.
  • Anixa Biosciences Inc annual Operating Income (Loss) for 2023 was -$11M, a 20.6% increase from 2022.
  • Anixa Biosciences Inc annual Operating Income (Loss) for 2022 was -$13.9M, a 5.63% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Anixa Biosciences Inc Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$12M -$2.44M +$1.16M +32.2% 01 May 2025 31 Jul 2025 10-Q 10 Sep 2025
Q1 2025 -$13.1M -$3M +$464K +13.4% 01 Feb 2025 30 Apr 2025 10-Q 28 May 2025
Q4 2024 -$13.6M -$3.39M +$223K +6.18% 01 Nov 2024 31 Jan 2025 10-Q 11 Mar 2025
Q3 2024 -$13.8M -$3.16M -$112K -3.67% 01 Aug 2024 31 Oct 2024 10-K 10 Jan 2025
Q2 2024 -$13.7M -$3.59M -$748K -26.3% 01 May 2024 31 Jul 2024 10-Q 10 Sep 2025
Q1 2024 -$13M -$3.47M -$907K -35.4% 01 Feb 2024 30 Apr 2024 10-Q 28 May 2025
Q4 2023 -$12.1M -$3.61M -$1.05M -41.2% 01 Nov 2023 31 Jan 2024 10-Q 11 Mar 2025
Q3 2023 -$11M -$3.05M +$558K +15.5% 01 Aug 2023 31 Oct 2023 10-K 10 Jan 2025
Q2 2023 -$11.6M -$2.84M -$47K -1.68% 01 May 2023 31 Jul 2023 10-Q 06 Sep 2024
Q1 2023 -$11.5M -$2.56M +$1.03M +28.7% 01 Feb 2023 30 Apr 2023 10-Q 04 Jun 2024
Q4 2022 -$12.6M -$2.56M +$1.32M +34.1% 01 Nov 2022 31 Jan 2023 10-Q 12 Mar 2024
Q3 2022 -$13.9M -$3.61M +$469K +11.5% 01 Aug 2022 31 Oct 2022 10-K 16 Jan 2024
Q2 2022 -$14.3M -$2.8M +$1.59M +36.3% 01 May 2022 31 Jul 2022 10-Q 06 Sep 2023
Q1 2022 -$15.9M -$3.59M -$1.15M -47.3% 01 Feb 2022 30 Apr 2022 10-Q 14 Jun 2023
Q4 2021 -$14.8M -$3.88M -$1.65M -73.8% 01 Nov 2021 31 Jan 2022 10-Q 17 Mar 2023
Q3 2021 -$13.1M -$4.08M -$1.84M -81.9% 01 Aug 2021 31 Oct 2021 10-K 04 Jan 2023
Q2 2021 -$11.3M -$4.39M -$1.95M -80.1% 01 May 2021 31 Jul 2021 10-Q 09 Sep 2022
Q1 2021 -$9.35M -$2.44M +$233K +8.73% 01 Feb 2021 30 Apr 2021 10-Q 10 Jun 2022
Q4 2020 -$9.58M -$2.23M +$397K +15.1% 01 Nov 2020 31 Jan 2021 10-Q 11 Mar 2022
Q3 2020 -$9.98M -$2.24M -$114K -5.34% 01 Aug 2020 31 Oct 2020 10-K 04 Jan 2022
Q2 2020 -$9.86M -$2.44M -$252K -11.5% 01 May 2020 31 Jul 2020 10-Q 01 Sep 2021
Q1 2020 -$9.61M -$2.67M -$76.9K -2.97% 01 Feb 2020 30 Apr 2020 10-Q 10 Jun 2021
Q4 2019 -$9.54M -$2.63M +$2.35M +47.2% 01 Nov 2019 31 Jan 2020 10-Q 11 Mar 2021
Q3 2019 -$11.9M -$2.13M +$3.28M +60.6% 01 Aug 2019 31 Oct 2019 10-K 07 Jan 2021
Q2 2019 -$15.2M -$2.18M +$3.42M +61% 01 May 2019 31 Jul 2019 10-Q 08 Sep 2020
Q1 2019 -$18.6M -$2.59M -$1.19M -85.1% 01 Feb 2019 30 Apr 2019 10-Q 09 Jun 2020
Q4 2018 -$17.4M -$4.98M -$3.11M -166% 01 Nov 2018 31 Jan 2019 10-Q 09 Mar 2020
Q3 2018 -$14.3M -$5.41M -$3.67M -211% 01 Aug 2018 31 Oct 2018 10-K 09 Jan 2020
Q2 2018 -$10.6M -$5.61M -$3.87M -224% 01 May 2018 31 Jul 2018 10-Q 06 Sep 2019
Q1 2018 -$6.74M -$1.4M -$189K -15.6% 01 Feb 2018 30 Apr 2018 10-Q 12 Jun 2019
Q4 2017 -$6.56M -$1.87M -$480K -34.4% 01 Nov 2017 31 Jan 2018 10-Q 13 Mar 2019
Q3 2017 -$6.08M -$1.74M -$824K -90.3% 01 Aug 2017 31 Oct 2017 10-K 11 Jan 2019
Q2 2017 -$5.25M -$1.73M -$756K -77.6% 01 May 2017 31 Jul 2017 10-Q 07 Sep 2018
Q1 2017 -$4.5M -$1.21M -$63.6K -5.54% 01 Feb 2017 30 Apr 2017 10-Q 11 Jun 2018
Q4 2016 -$4.43M -$1.39M +$77.5K +5.26% 01 Nov 2016 31 Jan 2017 10-Q 09 Mar 2018
Q3 2016 -$4.51M -$913K +$264K +22.4% 01 Aug 2016 31 Oct 2016 10-K 09 Jan 2018
Q2 2016 -$4.77M -$975K +$516K +34.6% 01 May 2016 31 Jul 2016 10-Q 08 Sep 2017
Q1 2016 -$5.29M -$1.15M +$985K +46.2% 01 Feb 2016 30 Apr 2016 10-Q 26 May 2017
Q4 2015 -$6.27M -$1.47M -$5.33M -138% 01 Nov 2015 31 Jan 2016 10-Q 16 Mar 2017
Q3 2015 -$945K -$1.18M +$387K +24.7% 01 Aug 2015 31 Oct 2015 10-K 08 Dec 2016
Q2 2015 -$1.33M -$1.49M -$1.33M -834% 01 May 2015 31 Jul 2015 10-Q 19 Aug 2016
Q1 2015 -$565 -$2.13M -$778K -57.4% 01 Feb 2015 30 Apr 2015 10-Q 20 May 2016
Q4 2014 $777K $3.86M +$5.82M 01 Nov 2014 31 Jan 2015 10-Q 19 Feb 2016
Q3 2014 -$5.04M -$1.56M +$211K +11.9% 01 Aug 2014 31 Oct 2014 10-K 23 Dec 2015
Q2 2014 -$5.25M -$160K +$2.06M +92.8% 01 May 2014 31 Jul 2014 10-Q 18 Aug 2015
Q1 2014 -$7.31M -$1.36M +$496K +26.8% 01 Feb 2014 30 Apr 2014 10-Q 22 May 2015
Q4 2013 -$7.81M -$1.96M +$108K +5.21% 01 Nov 2013 31 Jan 2014 10-Q 09 Mar 2015
Q3 2013 -$7.92M -$1.78M -$49.5K -2.87% 01 Aug 2013 31 Oct 2013 10-K 29 Jan 2015
Q2 2013 -$7.87M -$2.22M -$1.58M -245% 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014
Q1 2013 -$6.29M -$1.85M -$973K -111% 01 Feb 2013 30 Apr 2013 10-Q 16 Jun 2014
Q4 2012 -$5.32M -$2.07M -$1.19M -134% 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014
Q3 2012 -$4.13M -$1.73M -$719K -71.4% 01 Aug 2012 31 Oct 2012 10-K/A 17 Jan 2014
Q2 2012 -$3.42M -$643K +$564K +46.7% 01 May 2012 31 Jul 2012 10-Q/A 20 Sep 2013
Q1 2012 -$3.98M -$878K +$409K +31.8% 01 Feb 2012 30 Apr 2012 10-Q/A 19 Jun 2013
Q4 2011 -$4.39M -$887K +$639K +41.9% 01 Nov 2011 31 Jan 2012 10-Q/A 25 Mar 2013
Q3 2011 -$5.03M -$1.01M 01 Aug 2011 31 Oct 2011 10-K 29 Jan 2013
Q2 2011 -$1.21M +$62.6K +4.93% 01 May 2011 31 Jul 2011 10-Q 14 Sep 2012
Q1 2011 -$1.29M 01 Feb 2011 30 Apr 2011 10-Q 14 Jun 2012
Q4 2010 -$1.53M 01 Nov 2010 31 Jan 2011 10-Q 16 Mar 2012
Q2 2010 -$1.27M 01 May 2010 31 Jul 2010 10-Q/A 14 Oct 2011

Anixa Biosciences Inc Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$13.8M -$2.82M -25.6% 01 Nov 2023 31 Oct 2024 10-K 10 Jan 2025
2023 -$11M +$2.86M +20.6% 01 Nov 2022 31 Oct 2023 10-K 10 Jan 2025
2022 -$13.9M -$739K -5.63% 01 Nov 2021 31 Oct 2022 10-K 16 Jan 2024
2021 -$13.1M -$3.16M -31.6% 01 Nov 2020 31 Oct 2021 10-K 04 Jan 2023
2020 -$9.98M +$1.91M +16.1% 01 Nov 2019 31 Oct 2020 10-K 04 Jan 2022
2019 -$11.9M +$2.4M +16.8% 01 Nov 2018 31 Oct 2019 10-K 07 Jan 2021
2018 -$14.3M -$8.21M -135% 01 Nov 2017 31 Oct 2018 10-K 09 Jan 2020
2017 -$6.08M -$1.57M -34.7% 01 Nov 2016 31 Oct 2017 10-K 11 Jan 2019
2016 -$4.51M -$3.56M -377% 01 Nov 2015 31 Oct 2016 10-K 09 Jan 2018
2015 -$945K +$4.1M +81.3% 01 Nov 2014 31 Oct 2015 10-K 08 Dec 2016
2014 -$5.04M +$2.87M +36.3% 01 Nov 2013 31 Oct 2014 10-K 23 Dec 2015
2013 -$7.92M -$3.78M -91.5% 01 Nov 2012 31 Oct 2013 10-K 29 Jan 2015
2012 -$4.13M +$894K +17.8% 01 Nov 2011 31 Oct 2012 10-K/A 17 Jan 2014
2011 -$5.03M +$220K +4.19% 01 Nov 2010 31 Oct 2011 10-K 29 Jan 2013
2010 -$5.25M 01 Nov 2009 31 Oct 2010 10-K 30 Jan 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.